Search
Close this search box.

Interventions to Improve HPV Vaccine Coverage

Interventions to Improve HPV Vaccine Coverage

The World Health Organization (WHO) proposes four main strategies to achieve the goal of 90% HPV vaccine coverage [1]. 1) Ensure the adequacy and affordability of HPV vaccine: Improving HPV vaccine accessibility by overcoming vaccine supply challenges through collaboration with non-governmental organizations (NGOs), private institutions, and other stakeholders. At the same time, promoting vaccine affordability through market-based intervention while ensuring a healthy market mechanism. 2) Improve vaccine quality and coverage: Enhancing vaccine coverage for vulnerable groups (e.g., out-of-school children and adolescents) through multi-sector collaborations (e.g., integration with school-based immunization programs), innovating community-based vaccination programs, and establishing registry/monitor systems to track and improve vaccine coverage. 3) Improve communication and advocacy: Enhancing awareness of the HPV vaccine should rely on nationwide evidence-based communication and advocacy. To better manage the spread of misinformation about vaccination and eliminate vaccine fear and hesitancy, it is necessary to understand the social and cultural factors that influence vaccination acceptance and conduct effective communication and health education. 4) Improve the efficiency of vaccination: Improve vaccination efficiency by regularly revising national guidelines, policy documents, and strategic plans.

Previous studies have examined the effectiveness of various interventions.

1) For the vaccination target groups and communities, interventions include health education, social mobilization, reminders, incentives, and coercion;

2) For the vaccination workers and other healthcare providers, interventions include education and training, information-system-based reminders and health decision support, and retrospective evaluation and feedback;

3) From the vaccination and health system perspective, interventions include improving vaccine service coverage and implementing school-based immunization programs.

These interventions incorporate a variety of behavioral science theories, such as the health belief model, ecological frameworks, the theory of planned behavior, and protection motivation theory. They also employ behavioral change techniques like reminders and nudges. These strategies aim to create a social environment that encourages vaccination, enhances the coverage and efficiency of vaccination services, and positively influences individuals’ beliefs, attitudes, and behaviors regarding HPV vaccination [2].

Among these interventions, health education, vaccination reminders, and school-based immunization programs have strong evidence support. The study suggests policymakers integrate multiple intervention strategies (e.g., combining health worker training and health education for students and parents with SMS vaccination reminders) to effectively improve vaccination rates with consideration of the cost of intervention and the local context. The number of intervention studies conducted in China is limited; most focus on willingness and attitudes toward vaccination. Therefore, more implementation science studies are needed to explore the effectiveness of interventions among the Chinese population.

Vaccine-targeted populations often need to decide whether to receive the vaccine. For adolescents, this decision may be influenced by their parents’ or elders’ attitudes about vaccination. Effective communication, positive health education, reminders, and incentive strategies are necessary to enhance the target population’s and their caregivers’ understanding of the benefits, effects, and safety of HPV vaccines. These strategies can help develop positive attitudes, increase willingness to vaccinate, and build up a supportive environment to raise awareness and motivate vaccine uptake.

Health Education and Social Mobilization

Health education for HPV vaccination target groups and parents of adolescents and social mobilization targeting larger population groups are the most common interventions to raise awareness about vaccine safety and efficacy and increase vaccine coverage. After examining several randomized controlled studies conducted in the United States, the United Kingdom, and Sweden, a Cochrane review with high-quality evidence supports health education among adolescents and their parents, which can increase vaccination rates by nearly 43% (RR: 1.43, 95% CI: 1.16-1.76) [3]. This finding has been confirmed by other systematic reviews [4, 5].

Adolescents are often not yet capable of making independent vaccination decisions. Their parents or other legal guardians often decide whether or not to receive the vaccine. In this case, health education can facilitate adolescents’ and parents’ understanding of vaccination risks and benefits, vaccination procedures, and related information. The World Health Organization suggests that girls should not be the only target of health education. Providing cervical cancer information to mothers of target girls and other older women is also an effective way to involve parents in the HPV vaccination decision-making process. At the same time, men (including fathers of target girls and other boys) should also receive education about HPV vaccines and cervical cancer. Health education targeting school teachers is another important intervention. Schools play a vital role in delivering vaccination education for adolescents. School leaders’ and teachers’ knowledge and attitudes about HPV vaccination significantly influence students’ and parents’ attitudes.

Health education could be carried out in various ways, including face-to-face conversation, telephone, text messages, lectures, and printed materials targeting the communities [6]. With the popularization of mobile devices in recent years, the dissemination of health videos, animations, and other promotional materials through the internet and social media has become a main channel of health education [7]. A retrospective study revealed that the evidence supporting the efficacy of social media in promoting vaccination rates requires further investigation. [8]. Another study found no significant difference between simplified and complex health education tools in improving vaccination outcomes [3]. However, health education materials targeting adolescents and their parents, or materials designed by adolescents or their parents, are more acceptable to the target group [5].

Health education materials should emphasize the prevalence of HPV infections, the vaccine’s safety and efficacy, dispel misconceptions, and clarify the vaccine’s role in cancer prevention. Meanwhile, it’s important to position the HPV vaccine as a routine and cancer prevention measure, not just as protection against sexually transmitted diseases. Therefore, health education and social mobilization intervention should be direct, simple, and effective, tailored to the target population’s primary sources of information, interests, knowledge level, and key barriers.

Vaccination Reminder

Moderate evidence supports that sending reminders to parents of adolescents can help increase HPV vaccination completion rates [9]. These include reminders for vaccinated individuals or their parents to receive subsequent doses at the prescribed times and encouraging those who have not completed the vaccination within the scheduled time. As communication channels evolve, reminders can be delivered through various formats, such as letters, emails, phone calls, text messages, and social media notifications [9]. In recent years, more evidence shows that utilizing the mHealth tools can effectively improve HPV vaccination and completion rates [10].

Incentive

Offering shopping vouchers or other incentives is also one way to increase vaccination rate and vaccination willingness. However, more research is needed to confirm its effectiveness. A positive cluster-controlled study was conducted in 60 schools in London and England, promoting HPV vaccination by offering a £50 shopping voucher to 8th-grade girls who completed informed consent. This study found that 87% of girls in the intervention group turned in their informed consent compared to 67% in the control group. Additionally, a higher percentage of parents of girls in the intervention group (76%) were supportive of HPV vaccination compared to the control group (61%) [11]. Another study conducted in the United Kingdom, where HPV vaccination was incentivized by giving shopping vouchers with a total value of approximately £45 to adolescents who had completed three doses of HPV vaccination, found that although the intervention was effective in increasing willingness to be vaccinated against HPV. It was not sufficient to achieve the vaccine coverage goal [12]. A systematic review also showed insufficient evidence to support the use of monetary incentives for parents to increase the vaccination of preschool children [13]. Therefore, additional studies are needed to verify whether incentives could promote HPV vaccination rates [7].

Mandatory Vaccination

Mandatory vaccination refers to making vaccination mandatory for school enrollment and requesting proof of vaccination records when they enroll in an education program. The current use of this tool has moderate evidence in promoting adolescent vaccinations such as Hepatitis B [7]. However, it has been used less frequently to increase HPV vaccination. The evidence was of weak certainty. A review included three observational studies from the United States, comparing vaccination in states that require mandatory immunization records with other regions. The studies found that while this tool may increase other vaccines’ uptake, it has limited or no effect in increasing HPV vaccination rates because students can often receive exemptions due to religious or medical reasons [9].

Primary care health providers are often the main source of HPV-related issues counseling for adolescents and their parents. Physicians’ prudent and impartial advice often guides parental decision-making and enhances adolescents’ willingness to be vaccinated. A meta-analysis of 59 studies revealed that compared with people who did not communicate with their doctors, people having conversations with healthcare providers and receiving the HPV vaccination recommendation outnumbered the percentage of first-dose HPV vaccination [14].

However, there are often concerns and barriers for healthcare workers in providing HPV vaccination advice to adolescents. For example, healthcare workers may be concerned that the HPV vaccine may encourage earlier or riskier sexual behaviors, causing some healthcare workers to delay giving the vaccination advice. Moreover, discussing HPV vaccination with adolescents or their guardians can be time-consuming. The time dedicated to vaccine counseling might reduce the availability of other health services, potentially diminishing job satisfaction. Under this circumstance, interventions such as education and training, information system reminders, and retrospective assessment and feedback need to be conducted to improve the HPV vaccine-related knowledge, attitudes, and behaviors of healthcare providers.

Education and Training

Training and education on HPV vaccines for healthcare workers can enhance their understanding and awareness, aiding the discussions with adolescents and their parents. Training typically includes written materials, videos, lectures, and continuing medical education programs. Several studies indicate that, compared to those who visited community clinics lacking HPV vaccine training, a higher proportion of adolescents who visited clinics received the training completed full vaccination. However, the evidence’s strength is relatively weak due to the absence of larger randomized controlled trials to confirm the intervention’s effectiveness [7].

Reminders and Medical Decision Support in the Information System

Some programs have embedded HPV vaccine-related reminders or decision support systems in health information technology systems for healthcare providers. When close to the vaccination deadlines, notifications will automatically prompt to remind healthcare workers to contact vaccine recipients. However, though healthcare professionals widely accept the strategy, its impact on increasing vaccination rates is limited. [9].

Retrospective Evaluation and Feedback

Retrospective evaluation, feedback, incentives, and exchanges of experiences regarding past immunization services could help improve the immunization service. For example, a study was conducted across 91 primary care settings in North Carolina, United States. The interventions included consultation with primary healthcare providers, evaluating the vaccination status of their served population, visualizing the data, and providing best practice training to healthcare workers. The interventions effectively increased immunization coverage over a five-month period, but the effect was limited over a one-year follow-up period. Further research is needed on the effectiveness of this type of intervention [15, 5].

Refining the vaccination organization, improving the vaccination strategies, enhancing vaccine accessibility, and boosting the efficiency of immunization services are interventions to improve the vaccine coverage.

Extending the Service Place and Time

Improving vaccination convenience is an important means of increasing vaccine coverage. Population-based vaccination programs are often implemented in healthcare facilities like community health centers. Some regions have piloted the service time extension, including weekend or holiday vaccination and service provision outside the healthcare facilities (e.g., mobile vaccination bus and walk-in vaccination service at the workplace). Studies also suggest that healthcare providers should seize every chance—such as emergency department visits or physical checks—to complete the adolescents’ vaccination at hospitals since they have rare chances to visit hospitals.

School-based Immunization Program

School-based vaccination strategies can effectively combine health education with vaccination services targeting adolescents. Several studies conducted in high-income countries (e.g., the United States, New Zealand) and in low- and middle-income countries have shown that, in areas with high enrollment of school girls, a school-based vaccination strategy achieves better vaccine accessibility, higher first-dose coverage, and higher full vaccination rates compared with vaccination at community clinics [9]. The success of this intervention is largely attributed to the school’s role in mobilizing resources, providing health education, and conducting follow-ups to ensure subsequent doses are administered. In addition, there is moderately strong evidence that better vaccine coverage can be achieved by implementing grade- and class-based vaccination strategies in schools than age-based vaccination strategies [7, 9].

The strategy also needs to consider the needs of out-of-school girls, especially those from vulnerable groups (e.g., migrant children, street children, etc.), to encourage them to complete vaccination in healthcare facilities or other venues that provide health services. For areas where the proportion of girls enrolled in school is relatively low, this can be done by combining it with other established interventions such as nutrition programs or polio immunization programs. [16].

Reduce Out-of-pocket Costs

Reducing the out-of-pocket costs of vaccination is an important means of increasing the affordability of vaccination. This goal can be achieved by subsidizing the cost of vaccines, reducing the cost, and adding to the commercial and public insurance package. In a retrospective cohort of free quadrivalent HPV vaccinations conducted in the Midwestern United States, charitable donations provided free HPV vaccinations targeting females aged 10-26 years who did not have public or private insurance or other financial resources. The study found that free vaccination did not improve the timely completion rates of the 3-dose series [17]. Therefore, intervention strategies targeting cost reduction to improve vaccine affordability require further research.

Utilizing single-dose vaccination, reducing the intervals between doses, and co-administering with other vaccines are vital strategies for enhancing vaccination compliance without compromising efficacy and safety. For example, studies indicate the HPV9 vaccine could be co-administered with MCV4 and Tdap vaccines [18] or concomitantly with REPEVAX (the combination of diphtheria, tetanus, pertussis, and poliomyelitis vaccines) [19]. The co-administrations were generally well tolerated and did not interfere with the immune response to either vaccine. However, studies on shortening the HPV vaccination intervals and co-administration with other vaccines are limited.

A growing number of regions have adopted strategies to apply the abovementioned interventions. We could apply proper interventions targeting different stakeholders to tackle the implementation barriers and integrate the vaccination service with the existing health system to improve vaccine coverage. Moderate-strength evidence supports the multiple interventions targeting healthcare providers and adolescents, which could effectively increase the vaccination rate and compliance to complete the vaccination. A study also found the integrated intervention targeting parents and healthcare providers could increase the vaccination rates at 3- and 6-month post-intervention follow-up periods, although the evidence strength is relatively weak [3].


Content Reviewer: Kelly Hunter, Menglu Jiang, Zhangyang Pan, Houser Chen

Page Editor: Jiaqi Zu


References:

  1. References. World Health Organization: Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020.
  2. Batista Ferrer H, Audrey S, Trotter C, Hickman M: An appraisal of theoretical approaches to examining behaviours in relation to Human Papillomavirus (HPV) vaccination of young womenPreventive Medicine 2015, 81:122-131.
  3. Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS: Improving vaccination uptake among adolescentsCochrane Database of Systematic Reviews 2020(1).
  4. Jaca A, Mathebula L, Iweze A, Pienaar E, Wiysonge CS: A systematic review of strategies for reducing missed opportunities for vaccinationVaccine 2018, 36(21):2921-2927.
  5. Dempsey AF, Zimet GD: Interventions to Improve Adolescent Vaccination: What May Work and What Still Needs to Be TestedVaccine 2015, 33:D106-D113.
  6. Fu LY, Bonhomme L-A, Cooper SC, Joseph JG, Zimet GD: Educational interventions to increase HPV vaccination acceptance: A systematic reviewVaccine 2014, 32(17):1901-1920.
  7. Acampora A, Grossi A, Barbara A, Colamesta V, Causio FA, Calabrò GE, Boccia S, de Waure C: Increasing HPV vaccination uptake among adolescents: A systematic reviewInternational journal of environmental research and public health 2020, 17(21):7997.
  8. Odone A, Ferrari A, Spagnoli F, Visciarelli S, Shefer A, Pasquarella C, Signorelli C: Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage: a systematic reviewHuman vaccines & immunotherapeutics 2015, 11(1):72-82.
  9. Smulian EA, Mitchell KR, Stokley S: Interventions to increase HPV vaccination coverage: a systematic reviewHuman vaccines & immunotherapeutics 2016, 12(6):1566-1588.
  10. Ilozumba O, Schmidt P, Ket JCF, Jaspers M: Can mHealth interventions contribute to increased HPV vaccination uptake? A systematic reviewPreventive Medicine Reports 2021, 21:101289.
  11. Forster AS, Cornelius V, Rockliffe L, Marlow LAV, Bedford H, Waller J: A cluster randomised feasibility study of an adolescent incentive intervention to increase uptake of HPV vaccinationBritish Journal of Cancer 2017, 117(8):1121-1127.
  12. Mantzari E, Vogt F, Marteau TM: Financial incentives for increasing uptake of HPV vaccinations: a randomized controlled trialHealth Psychology 2015, 34(2):160.
  13. Wigham S, Ternent L, Bryant A, Robalino S, Sniehotta FF, Adams J: Parental financial incentives for increasing preschool vaccination uptake: systematic reviewPediatrics 2014, 134(4):e1117-e1128.
  14. Oh NL, Biddell CB, Rhodes BE, Brewer NT: Provider communication and HPV vaccine uptake: A meta-analysis and systematic reviewPreventive Medicine 2021, 148:106554.
  15. Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, Brewer NT: Increasing provision of adolescent vaccines in primary care: a randomized controlled trialPediatrics 2014, 134(2):e346-e353.
  16. Wigle J, Coast E, Watson-Jones D: Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospectsVaccine 2013, 31(37):3811-3817.
  17. Harper DM, Verdenius I, Harris GD, Barnett AL, Rosemergey BE, Arey AM, Wall J, Malnar GJ: The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose seriesPreventive Medicine 2014, 61:20-25.
  18. Schilling, A., Parra, M. M., Gutierrez, M., Restrepo, J., Ucros, S., Herrera, T., Engel, E., Huicho, L., Shew, M., Maansson, R., Caldwell, N., Luxembourg, A., & Ter Meulen, A. S. (2015). Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines. Pediatrics, 136(3), e563–e572.
  19. Kosalaraksa, P., Mehlsen, J., Vesikari, T., Forstén, A., Helm, K., Van Damme, P., Joura, E. A., Ciprero, K., Maansson, R., Luxembourg, A., & Sobanjo-ter Meulen, A. (2015). An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age. The Pediatric infectious disease journal, 34(6), 627–634.

代表性地区的基本情况、接种政策及效果、宣传推动情况

(1) 成都市

 

基本情况

成都市2022年度GDP为20817.5亿元,排名全国城市第七。成都市出台了《健康城市建设推动健康中国行动创新模式成都市宫颈癌综合防控试点工作方案》等一系列相关政策推动适龄女孩HPV疫苗接种工作。

接种政策及效果

目标人群为13-14岁在校且无HPV疫苗接种史女生。免疫程序为国产二价0-6二剂次、进口二价0-1-6三剂次、进口四价0-2-6三剂次。资助政策为国产二价疫苗(沃泽惠)免费,其它疫苗补贴600元/人,并自付20元/剂接种费。疫苗接种按照属地化管理原则,由学校所在地预防接种单位负责。截至2022年1月,目标人群首针接种率达90.04%[14]。

宣传推动

成都市开展多形式、多载体的健康教育宣传。形式包括讲座、知晓日、义诊咨询、专题课程、专题活动等,载体包括宣传册、宣传栏、展板、电视、微信、视频号、抖音平台等,覆盖相关医疗机构300余、社区300余个、和公众场所90余个。面向适龄女孩及监护人、适龄女性及全体市民开展广泛宣教,宣传材料发放至近9万名群众,讲座活动覆盖近2万名群众。宣教内容包括HPV疫苗接种、两癌防控、其它女性常见疾病防控等。

(2) 济南市

 

基本情况

济南市2022年度GDP为12027.5亿元,位列全国城市排名20。2021年,济南市出台《健康城市建设推动健康中国行动创新模式试点一济南市宫颈癌综合防治工作方案(2021—2025年)》等一系列相关政策推动适龄女孩HPV疫苗接种工作。

接种政策及效果

目标人群为≤14周岁且无HPV疫苗接种史的在校七年级女生。免疫程序为国产二价0-6二剂次。资助政策免费接种。疫苗接种按照属地化管理原则,安排分班级分时段前往学校所在地的预防接种单位进行接种。截至2022年11月,目标人群首针接种率达
94.4%[15].

宣传推动

济南市开展多形式、多载体的健康教育宣传。形式包括采访、线上线下专题活动,载体包括网络媒体、纸媒、科普展板、宣传手册、子宫颈癌与HPV疫苗知识读本、济南HPV疫苗接种手册,宣教人群广泛涵盖全体市民,宣教内容包括HPV疫苗接种、两癌防控等知识。

(3) 鄂尔多斯市

 

基本情况

鄂尔多斯市2022年度GDP为5613.44亿元,全国地级市第45位。2021年,鄂尔多斯市出台了《健康城市建设推动健康鄂尔多斯行动创新模式工作方案》等一系列相关政策推动适龄女孩HPV疫苗接种工作。

接种政策及效果

2020年8月,鄂尔多斯市在准格尔旗率先开展HPV疫苗免费接种项目。目标人群为全市当年13-18岁在校且无HPV疫苗接种史女生。免疫程序为进口二价0-1-6三剂次,

2023年起调整为13-14岁女孩0-6二剂次。资助政策为疫苗免费,自付20元/剂接种费。组织方式为疫苗接种服务中心根据任务安排联系学校,有规划的通知适龄女孩前来完成HPV疫苗接种。截至2022年11月,目标人群首针接种率接近70%[16]。

2022年8月,启动准格尔旗和达拉特旗高三女生接种四价和九价HPV疫苗的试点工作,利用暑假时间展开接种,力争在2023年年底达成90%的接种目标[17]。自鄂尔多斯之后,由政府主导的HPV疫苗惠民行动在多地等涌现。值得注意的是,近年来多主体参与到HPV疫苗支持项目,如慈善总会、医院、妇联等为主体单位牵头组织开展了一些公益活动。

宣传推动

鄂尔多斯市开展多形式、多载体的健康教育宣传。形式包括讲座、知晓日、义诊咨询、专题课程、专题活动等,载体包括宣传册、宣传栏、展板、电视、微信、视频号、抖音平台等,宣教人群广泛涵盖在校女孩及监护人,适龄女性及全体市民。宣教内容包括HPV疫苗接种、两癌防控、其它女性常见疾病防控等。

(4) 西安市

 

基本情况

西安市2022年度GDP为11486.51亿元,排名全国第22位。2021年,西安市出台了《西安市健康城市建设推动健康中国行动创新模式试点宫颈癌综合防治工作方案》等一系列相关政策推动适龄女孩HPV疫苗接种工作。

接种政策及效果

目标人群为全市年龄满13周岁(初中)在校女生。免疫程序为国产二价0-6二剂次,进口二价0-1-6三剂次,进口四价和进口九价0-2-6三剂次。接种政策为自愿自费。各区(县)合理设立HPV疫苗专项疫苗接种门诊承担接种任务,并及时将接种信息统一录入儿童免疫规划信息平台。

宣传推动

西安市出台了《西安市宫颈癌综合防治宣传方案》(市健办发〔2022〕12号)。通过媒体宣传、社区活动、义诊等形式,宣传册、宣传栏、展板、电视、微信公众号、报纸等载体普及宫颈癌防治相关知识。

(5) 西藏自治区

 

基本情况

西藏自治区2022年度GDP为2132.64亿元,经济总量整体规模相对其他省份较小,人均GDP处于全国中等偏下水平。2022年出台《西藏自治区妇女“两癌”综合防治工作实施方案》等系列政策推动适龄女孩HPV疫苗接种。

接种政策及效果

目标人群为13-14岁在校女生。免疫程序为国产二价0-6二剂次。资助政策为免费。由学校组织,接种者在商定接种时间携带个人身份证明材料与法定监护人一同前往定点接种单位接种。

宣传推动

充分利用网络、电视、广播、报刊等媒介,以群众喜闻乐见的宣传方式,对适龄在校女生HPV疫苗接种工作的意义及内容进行广泛宣传。

近年来各地HPV疫苗惠民项目信息

“疾病负担”指标解读

疾病负担(burden of disease, BOD)是指疾病造成的失能(伤残)、生活质量下降和过早死亡对健康和社会造成的总损失,包括疾病的流行病学负担和经济负担两个方面。

 

在疾病的流行病学方面,衡量疾病负担的常用指标包括传统指标和综合指标。

 

传统指标

传统疾病负担的衡量指标包括:用于描述和反映健康状况与水平的常规指标,如死亡人数、伤残人数和患病人数等绝对数指标;以及用来比较不同特征人群疾病分布差异的指标,如发病率、伤残率、患病率、死亡率、门诊和住院率等相对数指标。

 

上述传统疾病负担的衡量指标基本上只考虑了人口的生存数量,而忽略了生存质量,不够全面;但优势在于资料相对计算方便,结果直观,可用于各种疾病的一般性描述。

 

综合指标

疾病负担不等同于死亡人数,综合指标弥补了传统指标的单一性,且可以让各种不同疾病造成的负担之间相互比较。

 

潜在寿命损失年(YPLL):通过疾病造成的寿命损失来估计疾病负担的大小。但忽略了疾病造成的失能对生存质量的影响。

 

伤残调整寿命年(DALYs):将死亡和失能相结合,用一个指标来描述疾病的这两方面的负担。它包括因早死造成健康生命年的损失(YLL)和因伤残造成健康生命年的损失(YLD),即DALY=YLL+YLD。目前,DALY是国内外一致公认的最具代表性、运用最多的疾病负担评价指标。

 

健康期望寿命(HALE):指具有良好健康状态的生命年以及个体在比较舒适的状态下生活的平均预期时间,综合考虑生命的质量和数量两方面。

 

 

随着疾病负担研究的深入,其测量范围从流行病学负担扩大到经济负担。

 

疾病经济负担是由于发病、伤残(失能)和过早死亡给患者本人、家庭以及社会带来的经济损失,和由于预防治疗疾病所消耗的经济资源。

详细见:疾病的“经济负担”怎么计算?

 

参考资料:

陈文. 卫生经济学 [M]. 人民卫生出版社. 2017.

李茜瑶,周莹,黄辉等.疾病负担研究进展[J].中国公共卫生,2018,34(05):777-780.

什么是“年龄标化”?

在流行病学研究中,年龄是多种疾病的危险因素。以发病率为例,该指标反映了一定时期内,特定人群中癌症新发病例的情况。由于年龄是癌症发生的一个重要影响因素,年龄越大,发病率就越高。

 

如果两个国家的人群年龄结构相差很大,例如A市老年人口比例更大,B市年轻人口占比更高,直接比较两地癌症发病率的高低,我们不能确定发病率较高的市,是因为年龄构成不同还是因为其他影响因素(如饮食习惯、环境等)所导致。因此,需要用“年龄标化”的统计学方法,进一步处理数据,排除年龄影响因素的干扰,再来比较两地的发病率数据。

 

以发病率为例,即把原始数据套到一个“标准年龄结构人群里”,计算出”年龄标化发病率“,这样人群结构不同的A市和B市,就能在同一个指标尺度下进行“发病率”比较。年龄标化通常有“中标率”,即我国各地基于某一年份的中国人口年龄结构构成作为标准计算,国内不同地区的疾病数据比较采用的是“中标率”;另一种是“世标率”,即用世界标准人口构成机型标化计算,适用于国与国之间的指标比较。

 

同样地,以死亡率为例,应特别注意各之间地人口构成的差异。用标准化死亡率进行比较才能得出正确结论。如甲、乙两地在未标化前的肺癌死亡率相同,但实际上乙地人群的肺癌死亡率要明显地高于甲地,其原因在于甲地男性老年人口居多,而肺癌的死亡率又与年龄和性别有关,所以用未标化率进行比较时,就会得出甲乙两地肺癌死亡率相同的错误结论。

 

参考资料:

 

张科宏教授:年龄标化的患病率 – 丁香公开课 (dxy.cn)

科学网—癌症(粗)发病率与标化发病率的区别 – 杨雷的博文 (sciencenet.cn)

WHO年龄标化死亡率定义及计算方法

沈洪兵,齐秀英. 流行病学 [M]. 人民卫生出版社. 2015.

疾病的“经济负担”怎么计算?

疾病经济负担是由于发病、伤残(失能)和过早死亡给患者本人、家庭以及社会带来的经济损失,和由于预防治疗疾病的费用。通过计算疾病的经济负担,可以从经济层面上研究或比较不同疾病对人群健康的影响。

总疾病经济负担包括直接疾病经济负担、间接疾病经济负担和无形疾病经济负担。

直接经济负担:指直接用于预防和治疗疾病的总费用,包括直接医疗经济负担和直接非医疗经济负担两部分。直接医疗经济负担是指在医药保健部门购买卫生服务的花费,主要包括门诊费(如挂号费、检查费、处置费、诊断费、急救费等)、住院费(如手术费、治疗费等)和药费等。直接非医疗经济负担包括和疾病有关的营养费、交通费、住宿费、膳食费、陪护费和财产损失等。

间接经济负担:指由于发病、伤残(失能)和过早死亡给患者本人和社会带来的有效劳动力损失而导致的经济损失。具体包括:劳动工作时间损失、个人工作能力和效率降低造成的损失、陪护病人时损失的劳动工作时间、精神损失等。

无形经济负担:指患者及亲友因疾病在心理、精神和生活上遭受的痛苦、悲哀、不便等生活质量下降而产生的无形损失。

 

参考资料:

陈文. 卫生经济学 [M]. 人民卫生出版社. 2017.

李茜瑶,周莹,黄辉等.疾病负担研究进展[J].中国公共卫生,2018,34(05):777-780.